Dyne Therapeutics, Inc. · NASDAQ:DYN
Lucera Erick sold 5,727 Dyne Therapeutics, Inc. shares (Form 4)
Traded Apr 1, 2026 · Filed Apr 3, 2026
On Apr 1, 2026, Lucera Erick (Chief Financial Officer) sold 5,727 Dyne Therapeutics, Inc. shares at US$18.64 for US$107K under a trading plan, leaving 125,373 shares. Filed Apr 3, 2026 (Form 4).
- Sold
- 5,727 shares
- Price
- US$18.64
- Value
- US$107K
- Holding after
- 125,373 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | Common Stock | Sale | 5,727 | US$18.64 | 125,373 | Direct |
Source
Related
- Dyne Therapeutics, Inc.
- Lucera Erick
- Dyne Therapeutics, Inc. shareholders
- Form 4 · Lucera Erick · Aug 17, 2026
- Form 4 · Lucera Erick · Jun 26, 2026
- Form 4 · Lucera Erick · May 14, 2026
- Form 4 · Posner Brian S · Oct 6, 2026
- Form 4 · Friedl-Naderer Johanna · Sep 8, 2026
- Form 4 · Cox John · Sep 8, 2026
- Form 4 · Kerr Douglas · Sep 8, 2026
- Form 4 · Rhodes Jason P · Aug 17, 2026